These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 471320)
21. [Diagnostic value of determining middle molecules in the blood plasma in nephrological diseases]. Gabriélian NI; Dmitriev AA; Kulakov GP; Melikian AM; Shcherbaneva OI Klin Med (Mosk); 1981 Oct; 59(10):38-42. PubMed ID: 7311409 [No Abstract] [Full Text] [Related]
22. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance. Gallice P; Monti JP; Crevat A; Durand C; Murisasco A Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate. Ringoir SM; van Landschoot N; de Smet R Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359 [TBL] [Abstract][Full Text] [Related]
30. Middle molecules in uraemia. Fürst P; Asaba M; Gordon A; Zimmerman L; Bergström J Proc Eur Dial Transplant Assoc; 1975; 11():417-26. PubMed ID: 1105558 [No Abstract] [Full Text] [Related]
31. Search for peptidic "middle molecules" in uremic sera: isolation and chemical identification of fibrinogen fragments. Kaplan B; Cojocaru M; Unsworth E; Knecht A; Martin BM J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):141-53. PubMed ID: 14552825 [TBL] [Abstract][Full Text] [Related]
32. Reagents for the chemical development of latent fingerprints: synthesis and properties of some ninhydrin analogues. Almog J; Hirshfeld A; Klug JT J Forensic Sci; 1982 Oct; 27(4):912-7. PubMed ID: 7175471 [TBL] [Abstract][Full Text] [Related]
33. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2. Le Moel G; Strecker G; Cueille G; Boudet J; Man NK; Galli A; Agneray J Artif Organs; 1981; 4 Suppl():17-21. PubMed ID: 7295087 [TBL] [Abstract][Full Text] [Related]
34. Middle molecules in uremic serum, urine and dialysis fluid. Migone L; Dall'taglio P; Buzio C Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803 [TBL] [Abstract][Full Text] [Related]
35. [Letter: Moberg's ninhydrin sweat test for the diagnosis of retroperitoneal lymph-node tumors and pancoast syndromes]. Mohr B Dtsch Med Wochenschr; 1976 Jul; 101(27):1041. PubMed ID: 1278036 [No Abstract] [Full Text] [Related]
36. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography]. Kovalishin IaF; Nikolaev VG; Baran EIa; Dudar' IA; Iushko LA Vopr Med Khim; 1988; 34(6):23-6. PubMed ID: 3238937 [TBL] [Abstract][Full Text] [Related]
38. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]]. Popławski A; Myśliwiec M; Soszka J Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374 [TBL] [Abstract][Full Text] [Related]
39. [Biochemical definition of uremia]. Ringoir S Verh K Acad Geneeskd Belg; 1981; 43(2):105-19. PubMed ID: 7314875 [No Abstract] [Full Text] [Related]
40. [Studies on the significance of middle molecular retention products as uremia toxins]. Goubeaud G; Leber HW; Schott HH Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1244-6. PubMed ID: 611827 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]